Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytes

Journal of Orthopaedic Research

Volumn 18, Issue 4, 2000, Pages 585-592

  Shuler, Franklin D ^a   Georgescu, Helga I ^a   Niyibizi, Christopher ^a   Studer, Rebecca K ^a   Mi, Zhibao ^a   Johnstone, Brian ^b   Robbins, Paul D ^a   Evans, Christopher H ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; COLLAGEN; GROWTH KINETICS;

ARTICULAR CHONDROCYTES; GROWTH FACTOR; MONOLAYER CULTURES;

CARTILAGE;

COLLAGEN TYPE 2; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1;

ADENOVIRUS; ANIMAL CELL; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CLONING VECTOR; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; EXTRACELLULAR MATRIX; GENE TRANSFER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; TRANSCRIPTION REGULATION; WOUND HEALING;

EID: 0034232660     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100180411     Document Type: Article

References (34)

1. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β
2. 1 and heat shock protein 70 gene transduction
3. The synovial activation of chondrocytes: Evidence for complex cytokine interactions involving a possible novel factor
4. Transplantation of transduced chondrocytes protects articular cartilage from interleukin- 1 induced extracellular matrix degradation
5. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo
6. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation
7. Nitric oxide inhibits the synthesis of type II collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target
8. Effects of growth factors on cartilage repair
9. Current concepts review. Possible orthopaedic applications of gene therapy
10. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
11. Gene therapy for rheumatic diseases
12. Lessons learned from gene therapy approaches
13. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-β into murine knee joints
14. rhMP-2 residence in rabbit full-thickness cartilage defects
15. Behavior of articular chondrocytes in cell culture
16. Construction of adenovirus vectors through Cre-lox recombination
17. Repair of partial-thickness defects in articular cartilage: Cell recruitment from the synovial membrane
18. 1
19. Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells
20. Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: A feasibility study
21. Osteoarthritic human cartilage is more sensitive to transforming growth factor β than in normal cartilage
22. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis
23. Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ cultures
24. Transforming growth factor-β and insulin-like growth factor- 1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid
25. Current concepts review. The healing and regeneration of articular cartilage
26. Transforming growth factor β stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes
27. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β
28. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage
29. Transforming growth factor β: Recent progress and new challenges
30. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin- 1
31. Growth factors as therapeutic agents
32. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β1: Age-related differences
33. 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint
34. 1 on both articular cartilage composition and osteophyte formation